Cartesian Therapeutics, Inc. (RNAC) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US8162123025
Cartesian Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.80 m USD |
| Operating income | -143.41 m USD |
| EBIT | -146.07 m USD |
| Net income | -130.30 m USD |
| Diluted EPS – continuing operations | -5.02 USD |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.
More stocks
- Tantalus Systems Holding Inc (GRID.TO)
- Pengana International Equities Ltd (PIA.AX)
- Tcc Steel (002710.KS)
- Koskisen (KOSKI.HE)
- Taisun Enterprise Co Ltd (1218.TW)
- Saksiam Leasing Public Company Limited (SAK.BK)
- Decora SA (DCR.WA)
- Great Rich Technologies Limited (900290.KQ)
- Eledon Pharmaceuticals, Inc. (ELDN)
- Acon Optics Communications Inc. (6820.TWO)
- Lemtech Holdings Co Ltd (4912.TW)
- UeSTRA Hannoversche Verkehrsbetriebe (HVB.F)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.